TABLE 5.

Consumption of PGX drugs per sex and specific age groups.

	Number of PGX drug users per different Age groups
	0–4	5–14	15–24	25–44	45–64	65–74	75 +	Total	% per sex
2015
MEN	9,916	24,324	69,230	377,305	1,412,311	1,046,979	951,502	3,891,567	44.7
%	0.25	0.63	1.78	9.70	36.29	26.90	24.45
WOMEN	8,240	36,071	185,101	562,921	1,599,198	1,071,277	1,345,702	4,808,510	55.3
%	0.17	0.75	3.85	11.71	33.26	22.28	27.99
Total	18,156	60,395	254,331	940,226	3,011,509	2,118,256	2,297,204	8,700,077
%	0.21	0.69	2.81	10.70	34.77	24.59	26.22		100.0
2017
MEN	11,156	23,894	70,700	366,669	1,418,338	977,954	1,029,667	3,898,379	43.8
%	0.29	0.61	1.81	9.41	36.38	25.09	26.41
WOMEN	10,245	35,511	442,109	551,128	1,459,159	1,123,780	1,378,342	5,000,276	56.2
%	0.20	0.71	8.84	11.02	29.18	22.47	27.57
Total	21,401	59,405	512,809	917,798	2,877,498	2,101,735	2,408,009	8,898,655
%	0.24	0.67	5.76	10.31	32.34	23.62	27.06		100.0
2015+2017
MEN	21,072	48,218	139,930	743,974	2,830,649	2,024,933	1,981,169	7,789,946	44.2
%	0.27	0.62	1.80	9.55	36.34	25.99	25.43
WOMEN	18,485	71,582	627,210	1,114,049	3,058,357	2,195,057	2,724,044	9,808,786	55.8
%	0.19	0.73	6.39	11.36	31.18	22.38	27.77
Total	39,557	119,800	767,140	1,858,024	5,889,007	4,219,991	4,705,213	17,598,732
%	0.22	0.68	4.36	10.56	33.46	23.98	26.74		100.0